Control of myogenic tone and agonist induced contraction of intramural coronary resistance arterioles by cannabinoid type 1 receptors and endocannabinoids

Prostaglandins Other Lipid Mediat. 2018 Jan:134:77-83. doi: 10.1016/j.prostaglandins.2017.10.001. Epub 2017 Oct 16.

Abstract

It was tested whether intrinsic CB1R activation modifies myogenic and agonist induced contraction of intramural coronary resistance arteries of the rat. CB1R protein was detected by immuno-histochemistry and by Western blot, its mRNA by qRT-PCR in their wall. Microsurgically prepared cylindrical coronary segments (∼100-150μm) developed myogenic contraction (∼20% of relaxed luminal diameter), from which a substantial relaxation (∼15%) in response to WIN55212 (a specific agonist of the CB1Rs) has been found. CB1R-mediated relaxation was blocked by O2050 and AM251 (neutral antagonist and inverse agonist of the CB1R, respectively) and was partially blocked by the NO synthase blocker Nω-nitro-L-arginine. CB1R blockade enhanced myogenic tone and augmented AngII-induced vasoconstriction (from 17.8±1.2 to 29.1±2.9%, p<0.05). Inhibition of diacylglycerol lipase by tetrahydrolipstatin, (inhibitor of endogenous 2-AG production) also augmented coronary vasoconstriction. These observations prove that vascular endocannabinoids are significant negative modulators of the myogenic and agonist-induced tone of intramural coronary arterioles acting through CB1Rs.

Keywords: Angiotensin II; Cannabinoid; Coronary artery; Diacylglycerol; Vascular tone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arterioles / drug effects
  • Arterioles / physiology
  • Cannabinoids / pharmacology
  • Coronary Vessels / drug effects*
  • Coronary Vessels / physiology*
  • Dose-Response Relationship, Drug
  • Endocannabinoids / metabolism*
  • Gene Expression Regulation / drug effects
  • Lipoprotein Lipase / metabolism
  • Male
  • Rats
  • Rats, Wistar
  • Receptor, Cannabinoid, CB1 / agonists*
  • Receptor, Cannabinoid, CB1 / metabolism
  • Vasoconstriction / drug effects*

Substances

  • Cannabinoids
  • Endocannabinoids
  • Receptor, Cannabinoid, CB1
  • Lipoprotein Lipase